(Q40711632)
Statements
A phase I trial of a rhenium 186-labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: toxicity and clinical response (English)
Jacobs AJ
Fer M
Su FM
Breitz H
Thompson J
Goodgold H
Cain J
Heaps J